Does Semaglutide Cause Depression? What the Data Says

What the studies actually found

The biggest recent look came from a nine-site study of people with HIV, a group already at higher risk for depression, presented at a 2026 medical conference. After starting semaglutide, their depression scores barely moved.

The number to remember is minus 0.1. That was the average change in depression scores after roughly nine months on the drug, on a questionnaire where higher means worse. A change of minus 0.1 is a rounding error, not a mood crash.

Systematic reviews tell the same story in more formal terms. A 2026 meta-analysis pooled the numbers and found a small, non-significant bump in depression risk, about 25 percent higher, with a confidence interval that stretched from slightly lower to much higher. In statistics, a result like that means the effect could be real or could be nothing. The honest reading is no clear signal.

A separate look at four large semaglutide trials reached the same conclusion. Depression scores did not worsen, and fewer than one person in a hundred reported thoughts of suicide, a rate no different from the placebo group.

Why the scare took off

A few things collided. The drugs were new and suddenly everywhere. Depression is common in the first place, so some people taking any medicine will happen to feel worse while on it. And early anecdotal reports, including scattered accounts of feeling emotionally flat, spread faster than the careful follow-up data.

That flatness is worth naming, because it is the one mood change that keeps coming up from real users. Some describe a muted emotional range, a sense that food is not the only thing that got quieter. The scientists studying the drugs are candid that they do not fully understand what these medicines do inside the brain.

The surprise in the other direction

Here is the twist that does not fit a scare headline. Some evidence points the other way, toward mood possibly improving. In one experiment, monkeys given semaglutide drank less rum than monkeys on a placebo, a small but memorable hint that the drug tamps down cravings beyond food. Large observational studies have found GLP-1 users are less likely to be diagnosed with depression, not more.

A Cambridge scientist put the simpler theory plainly: losing the weight itself puts a positive spin on life. Nobody is claiming semaglutide is an antidepressant, and it is not approved as one. The claim is narrower and more honest: the scary thing many people read about did not hold up under scrutiny.

Three years after the first frightening reports, the evidence has settled into a duller, kinder shape. Semaglutide does not appear to cause depression. It might even help some people feel better, for reasons that have as much to do with the scale as the molecule. For now, the honest answer to a scary question is a calm one.